Comparative effect of human soluble insulin and insulin aspart upon hypoglycaemia-induced alterations in cardiac repolarization

British Journal of Clinical Pharmacology

Volumn 55, Issue 3, 2003, Pages 246-251

  Robinson, Robert T C E ^a   Harris, Nigel D ^a   Ireland, Robert H ^a   Lindholm, Anders ^b   Heller, Simon R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Novo Nordisk Ltd   (United Kingdom)

Author keywords

Human insulin; Hypoglycaemia; Insulin aspart; Ventricular repolarization

Indexed keywords

ADRENALIN; GLUCOSE; HUMAN INSULIN; INSULIN ASPART; POTASSIUM;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART REPOLARIZATION; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL; REGULATORY MECHANISM;

ADOLESCENT; ADULT; ARRHYTHMIA; DIABETIC ANGIOPATHIES; ELECTROPHYSIOLOGY; EPINEPHRINE; GLUCAGON; HEART VENTRICLES; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; NOREPINEPHRINE; POTASSIUM;

EID: 0037349293     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01726.x     Document Type: Article

References (36)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and the progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lances 1998; 352: 837-853.
3. Blundell T, Dodson G, Hodgkin D, Mercola D. Insulin. The structure in the crystal and its reflection in chemistry and biology. Adv Prot Chem 1972; 26: 279-402.
4. Brange J, Langkjaer L. Insulin structure and stability. Pharm Biotechnol 1993; 5: 315-350.
5. Barnett AH, Owens DR. Insulin analogues. Lancet 1997; 348: 47-51.
6. Heinemann L, Heise T, Jorgensen LN, Starke AAR. Action profile of the rapid acting insulin analog: human insulin B28Asp. Diabetic Med 1993; 10: 535-539.
7. Wiefels K, Hubinger A, Dannehland K, Gries FA. Insulin kinetic and dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analog (B28Asp). Horm Metab Res 1995; 27: 421-424.
8. Heinemann L, Weyer C, Rave K, Stiefelhagen O, Rauhaus M, Heise T. Comparison of the time-action profiles of U40-and U100-regular human insulin and the rapid-acting insulin analog B28 Asp. Exp Clin Endocrinol Diabetes 1997; 105: 140-144.
9. Heinemann L, Kapitza C, Starke AAR, Heise T. Time-action profile of the insulin analog B28Asp. Diabetic Med 1996; 13: 683-684.
10. Home PD, Lindholm A, Hylleberg B, Round P. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. Diabetes Care 1998; 21: 1904-1909.
11. Tattersall RB, Gill GV. Unexplained death of type 1 diabetic patients. Diabetic Med 1991; 8: 49-58.
12. Airey CM, Williams DDR, Martin PG, Bennett CMT, Spoor PA. Hypoglycaemia induced by exogenous insulin-human and animal insulin compared. Diabet Med 2000; 17: 416-432.
13. Egeli ES, Berkmen R. Action of hypoglycaemia on coronary insufficiency and mechanisms of ECG alterations. Am Heart J 1960; 59: 527-540.
14. Marques JL, George E, Peacey SR, et al. Altered ventricular repolarisation during hypoglycaemia in patients with diabetes. Diabetic Med 1997; 8: 648-654.
15. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31: 115-172.
16. Naas AAO, Davidson NC, Thompson C, et al. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin-dependent diabetes: cohort study. Br Med J 1998; 316: 745-746.
17. Harris ND, Heller SR. Sudden death in young patients with Type 1 diabetes. A consequence of disease, treatment or both? Diabetic Med 1999; 16: 623-625.
18. Alperin N, Sadeh D. An improved method for on-line averaging and detecting of ECG waveforms. Computers Biomed Res 1986; 19: 193-202.
19. Ireland RH, Robinson RTCE, Heller SR, Marques JLB, Harris ND. Measurement of high resolution ECG QT interval during controlled hypoglycaemia. Physiol Meas 2000; 21: 295-303.
20. Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342-344.
21. Ball SG, Tree M, Morton JJ, Inglis GC, Fraser R. Circulating dopamine: its effect on plasma concentration of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. Clin Sci 1981; 61: 417-422.
22. Ardill J. Radioimmunoassay of GI hormones. Clin Endocrinol Metab 1979; 8: 265-280.
23. Hazzard WR, Crockford PM, Buchanan KD, Vance JE, Chen R, Williams RH. A double antibody immunoassay for glucagon. Diabetes 1968; 17: 179-186.
24. Andersen L, Volund A, Olsen KJ, Plum A, Walsh D. Validity and use of a non-parallel insulin assay for pharmacokinetic studies of a rapid-acting insulin analog, insulin aspart. J Immunoassay 2002; in press.
25. Phillips KM. Power of the two one sided tests procedure in bioequivalence. J Pharmacokinet Biopharm 1990; 18: 137-144.
26. Kurtzhals P, Schaffer L, Sorensen A, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000; 49: 999-1005.
27. Frier BM, Ewing FME, Lindholm A, Hylleberg B, Kanc K. Symptomatic and counterregulatory hormonal responses to acute hypoglycaemia induced by insulin aspart and soluble human insulin in Type 1 diabetes. Diabetes Metab Res Rev 2000; 16: 262-268.
28. Collier A, Matthews DM, Young RJ, Clarke BF. Transient atrial fibrillation precipitated by hypoglycaemia: 2 case reports. Postgrad Med J 1987; 63: 895-897.
29. Soskin S, Katz LN, Strouse S, Rubinfeld SH. Treatment of elderly diabetic patients with cardiovascular disease. Available carbohydrate and the blood sugar level. Arch Intern Med 1932; 51: 122-142.
30. Diabetics concern about new insulin. Daily Telegraph, 17 August 1989.
31. Medical alert after mystery diabetic deaths. Daily Telegraph, 22 August 1989.
32. The European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products. The Assessment of the Potential for Qt Interval Prolongation by Non-Cardiovascular Medicinal Products. CPMP/986/96 1996.
33. Hill JA, Friedman PL. Measurement of QT interval and QT dispersion. Lancet 1997; 349: 894-895.
34. Kors JA, van Herpen G. Measurement error as a source of QT dispersion: a computerised analysis. Heart 1998; 80: 453-458.
35. Heller SR, MacDonald IA, Herbert M, Tattersall RB. Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet 1987; ii: 359-363.
36. Robinson RTCE, Ireland RH, Harris ND, Heller SR. Effects of beta-blockade on hypoglycaemia induced abnormalities of cardiac repolarization. Diabetes 1999; 48(Suppl 1): A57.